Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A420FY | ISIN: US0083893067 | Ticker-Symbol:
NASDAQ
13.02.26 | 21:49
2,210 US-Dollar
+6,25 % +0,130
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
AGAPE ATP CORPORATION Chart 1 Jahr
5-Tage-Chart
AGAPE ATP CORPORATION 5-Tage-Chart
ACCESS Newswire
583 Leser
Artikel bewerten:
(2)

Agape ATP Corporation Successfully Completes $23 Million Private Placement, Strengthening Growth Across Key Sectors

KUALA LUMPUR, MALAYSIA / ACCESS Newswire / March 25, 2025 / NASDAQ-listed AGAPE ATP Corporation ("ATPC") is pleased to announce the successful completion of its $23 million (USD) private placementexercise, reinforcing its financial strength as the company accelerates expansion into healthcare, oil & gas trading, and renewable energy. The strong participation of institutional investors reflects confidence in ATPC's long-term growth strategy, positioning the company for sustained market leadership across multiple industries.

To recap,the private placement involved the issuance of 46 million shares of common stock at USD 0.50 per share, under Regulation S of the U.S. Securities Act, which governs offerings to non-U.S. investors. The capital raised will be utilized to support ATPC's high-growth initiatives, including advancing oil & gas trading projects, scaling up its solar energy ventures, and enhancing its healthcare and wellness solutions.

Prof. Dato' Sri Dr How Kok Choong, Founder and Global Group CEO of ATPC

Prof Dato' Sri Dr How Kok Choong, the Founder and Global Group CEO of ATPC expressed gratitude for the overwhelming support from new and existing investors, stated: "The successful completion of this private placement is a testament to the strong market confidence in ATPC's vision and execution strategy. We are deeply grateful for the trust placed in us by institutional investors, which allows us to accelerate our expansion into high-value industries. With this fresh capital, we are well-positioned to enhance our operational capabilities, drive innovation, and create long-term value for our shareholders."

The completion of this funding round marks a pivotal moment for ATPC as it moves forward with several key initiatives. In the energy sector, ATPC's strategic partnership with Swiss One Oil & Gas AG is driving the procurement and distribution of refined fuel products, including EN590 10PPM diesel and Jet Fuel A1.

In addition to supporting its energy-related initiatives, ATPC will also utilize the proceeds to enhance its healthcare segment, further expanding its wellness and medical solutions to new markets. The capital infusion will strengthen product innovation, regulatory approvals, and commercialization efforts across ATPC's diverse portfolio.

About AGAPE ATP Corporation

Agape ATP Corporation (ATPC) is dedicated to enhancing the quality of life and promoting sustainable development. With a strong foundation built on two core business pillars, ATPC specialises in the provision of health and wellness products that caters to the diverse needs of its customers, ensuring their well-being and vitality. Additionally, APTC delivers comprehensive energy-saving solutions that empower companies to drive sustainability initiatives, reduce energy consumption, and achieve their sustainability goals. For more information, visit www.agapeatpgroup.com.

For more information, please contact:

Jazzmin Wan
Email: j.wan@swanconsultancy.biz

Mandy Tan
Email: m.tan@swanconsultancy.biz

FORWARD-LOOKING STATEMENT

Certain statements contained in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected benefits and outcomes of the partnerships announced by AGAPE ATP Corporation ("ATPC") and the potential for medical innovations and healthcare advancements through these collaborations. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the Company's ability to execute its strategies, manage growth, and maintain its corporate culture; the Company's future business development, financial conditions, and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Malaysia and the international markets the Company plans to serve, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and AGAPE ATP Corporation specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.

SOURCE: AGAPE ATP Corporation



© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.